FrancophonIA/ELRC3.0 huggingface dataset:
English: The recommended Cyltezo induction dose regimen for adult patients with moderate to severe ulcerative colitis is 160 mg at week 0 (given as four 40 mg injections in one day or as two 40 mg injections per day for two consecutive days) and 80 mg at week 2 (given as two 40 mg injections in one day).
Slovenian: Priporočena shema odmerjanja zdravila Cyltezo med indukcijo je pri odraslih bolnikih z zmerno do hudo aktivnim ulceroznim kolitisom 160 mg 0. teden (aplicirano kot štiri 40 mg injekcije v enem dnevu ali kot dve 40 mg injekciji na dan dva dni zapored) in 80 mg 2. teden (aplicirano kot dve 40 mg injekciji v enem dnevu).
English: Pulmonary embolism interstitial lung disease, chronic obstructive pulmonary disease, pneumonitis, pleural effusion
Slovenian: tuberkulozo in oportunistične okužbe, kongestivno srčno popuščanje, demielinizirajoče
English: Room spinning sensation (vertigo) and vision disturbances may occur after taking Cyltezo.
Slovenian: Po dajanju zdravila Cyltezo se lahko pojavita vrtoglavica (vertigo) in poslabšanje vida.
English: NAME OF THE MEDICINAL PRODUCT Cyltezo 40 mg solution for injection in pre-filled syringe Cyltezo 40 mg solution for injection in pre-filled pen
Slovenian: Cyltezo 40 mg raztopina za injiciranje v napolnjeni injekcijski brizgi Cyltezo 40 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku
English: There is no relevant use of adalimumab in children aged less than 6 years for this indication.
Slovenian: Adalimumab ni namenjen za uporabo pri otrocih, starih manj kot 6 let, za to indikacijo.
English: “Sharps” container (not included)
Slovenian: Vsebnik za ostre predmete (ni priložen)
English: Children, adolescents and adults from 6 years of age weighing 30 kg or more The recommended dose of Cyltezo is 40 mg every other week.
Slovenian: Otroci in mladostniki, starejši od 6 let, ki tehtajo 30 kg ali več Priporočeni odmerek zdravila Cyltezo je 40 mg vsak drugi teden.
English: • Discard Cyltezo pre-filled syringe into “sharps” container.
Slovenian: • Napolnjeno injekcijsko brizgo zdravila Cyltezo vrzite v vsebnik za ostre predmete.
English: Cyltezo 40 mg solution for injection in pre-filled syringe Each 0.8 mL single dose pre-filled syringe contains 40 mg of adalimumab.
Slovenian: Cyltezo 40 mg raztopina za injiciranje v napolnjeni injekcijski brizgi Ena 0,8 ml napolnjena injekcijska brizga z enim odmerkom vsebuje 40 mg adalimumaba.
English: 40 mg every week or 80 mg every other week
Slovenian: 10 mg vsak drugi teden 20 mg vsak drugi teden 20 mg vsak drugi teden 40 mg vsak drugi teden
English: Children, adolescents and adults from 2 years of age weighing 30 kg or more The recommended dose of Cyltezo is 40 mg every other week.
Slovenian: Otroci in mladostniki, starejši od 2 let, ki tehtajo 30 kg ali več Priporočeni odmerek zdravila Cyltezo je 40 mg vsak drugi teden.
English: EU/1/17/1240/008
Slovenian: EU/1/17/1240/005 1 napolnjen injekcijski peresnik EU/1/17/1240/006 2 napolnjena injekcijska peresnika EU/1/17/1240/007 4 napolnjeni injekcijski peresniki EU/1/17/1240/008 6 napolnjenih injekcijskih peresnikov
English: If your doctor considers that methotrexate is inappropriate,
Slovenian: Če vaš zdravnik meni, da metotreksat ni primeren, lahko zdravilo Cyltezo dobivate samo.
English: Response, Remission and Mucosal Healing in Study UC-II (Percent of Patients)
Slovenian: Preglednica 28: Odziv, remisija in celjenje sluznice v študiji UC-II (odstotek bolnikov) placebo adalimumab 40 mg vsak drugi teden
English: Cyltezo therapy should not be continued in patients failing to respond within this time period.
Slovenian: Pri bolnikih, ki se v tem času ne odzovejo, zdravljenja z zdravilom Cyltezo ni priporočljivo nadaljevati.
English: • 1 pre-filled pen (0.8 mL sterile solution) in a blister, with 2 alcohol pads.
Slovenian: • 1 napolnjen injekcijski peresnik (0,8 ml sterilne raztopine) v pretisnem omotu, z 2 alkoholnima
English: Nocturia
Slovenian: Norge
English: Ps Study I (REVEAL) - Efficacy Results at 16 Weeks
Slovenian: Preglednica 17: Študija pri psoriazi I (REVEAL) - rezultati učinkovitosti po 16 tednih placebo n = 398 n (%)
English: Adalimumab treated patients showed statistically significant improvements at week 26 compared with
Slovenian: Pri bolnikih, zdravljenih z adalimumabom, je prišlo do statistično značilnega izboljšanja dermatološkega indeksa kakovosti življenja (DLQI) po 26 tednih v primerjavi z placebom.
English: The combination of Cyltezo and anakinra is not recommended (see section 4.4 “Concurrent administration of
Slovenian: Zato kombinacija adalimumaba in anakinre ni priporočljiva (glejte poglavje 4.5).
English: • severe rash, hives or other signs of allergic reaction;
Slovenian: Poiščite urgentno zdravniško pomoč, če opazite kaj od naslednjega: • hud izpuščaj, koprivnico ali druge znake alergijske reakcije;
English: Cyltezo 40 mg solution for injection in pre-filled syringe
Slovenian: Cyltezo 40 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
English: • You might get infections more easily while you are receiving Cyltezo treatment.
Slovenian: • Med zdravljenjem z zdravilom Cyltezo se lahko poveča dovzetnost za okužbe.
English: Cyltezo dose for paediatric patients with uveitis
Slovenian: Preglednica 5: Odmerjanje zdravila Cyltezo pri pediatričnih bolnikih z uveitisom
English: Table 6:
Slovenian: Slika 3:
English: Two patients out of 3,441 treated with adalimumab in all rheumatoid arthritis and psoriatic arthritis studies developed clinical signs suggestive of new-onset lupus-like syndrome.
Slovenian: V vseh študijah revmatoidnega artritisa in psoriatičnega artritisa so se klinični znaki, ki so nakazovali novonastali lupusni sindrom, pojavili pri 2 od 3.441 bolnikov, zdravljenih z adalimumabom.
English: In patients with ulcerative colitis, a loading dose of 160 mg adalimumab on week 0 followed by 80 mg adalimumab on week 2 achieves serum adalimumab trough concentrations of approximately 12 μg/mL during the induction period.
Slovenian: Pri bolnikih z ulceroznim kolitisom doseže polnilni odmerek 160 mg adalimumaba na 0. teden, ki mu sledi 40 mg adalimumaba 2. teden, med obdobjem indukcije najmanjšo koncentracijo v serumu približno 12 µg/ml.
English: Talk to your doctor or pharmacist before using Cyltezo Allergic reaction
Slovenian: Pred začetkom uporabe zdravila Cyltezo se posvetujte z zdravnikom ali farmacevtom.
English: There is no relevant use of adalimumab in children aged less than 12 years in this indication.
Slovenian: Adalimumab ni namenjen za uporabo pri otrocih, mlajših od 12 let, za to indikacijo.
English: Cyltezo is intended for the treatment of the inflammatory diseases described below: • Polyarticular juvenile idiopathic arthritis,
Slovenian: Zdravilo Cyltezo je namenjeno za zdravljenje vnetnih bolezni, ki so opisane spodaj:
English: Preclinical data on postnatal toxicity of adalimumab are not available (see
Slovenian: Predkliničnih podatkov o poporodni toksičnosti adalimumaba ni (glejte poglavje 5.3).
English: • facial oedema associated with allergic reactions;
Slovenian: • artritisa, povezanega z entezitisom,
English: Cyltezo can reduce the number of nodules and abscesses you have and the pain that is often associated with the disease.
Slovenian: Zdravilo Cyltezo lahko zmanjša število vozličev in ognojkov, ki jih imate.
English: coccidioidomycosis or blastomycosis are endemic.
Slovenian: nesteroidnih protivnetnih zdravil ali analgetikov.
English: • Do not inject through clothes.
Slovenian: • Napolnjenih injekcijskih brizg NE vrzite med gospodinjske odpadke.
English: The usual dose for adults with psoriasis is an initial dose of 80 mg (as two 40 mg injections in one day), followed by 40 mg given every other week starting one week after the initial dose.
Slovenian: Običajni začetni odmerek za odrasle z luskavico (psoriazo) je 80 mg (dve 40 mg injekciji v enem dnevu), nato pa 40 mg vsak drugi teden z začetkom en teden po začetnem odmerku.
English: Rare postmarketing cases of hepatosplenic T-cell lymphoma have been identified in patients treated with adalimumab.
Slovenian: Pri bolnikih, zdravljenih z adalimumabom, je bil v redkih primerih med obdobjem trženja identificiran hepatosplenični T-celični limfom.
English: Continued therapy should be reconsidered in a patient not responding within this time period.
Slovenian: Po 12 tednih je treba nadaljevanje zdravljenja pri bolniku, pri katerem v tem obdobju ni prišlo do
English: Placebo Adalimumab 40 mg Weekly
Slovenian: placebo adalimumab
English: Anaphylaxis
Slovenian: Imunosupresija
English: • sensation of heart beating rapidly;
Slovenian: • občutek siljenja na bruhanje, bruhanje;
English: p-value p-value p-value p-value is from the pairwise comparison of methotrexate monotherapy and adalimumab/methotrexate combination therapy using the Mann-Whitney U test.
Slovenian: Vrednost p se nanaša na parno primerjavo monoterapije z metotreksatom in kombinirane terapije z adalimumabom/metotreksatom z Mann-Whitneyevim testom U.
English: • Do not rub the injection site.
Slovenian: Stisnite mesto injiciranja
English: If these medicines do not work well enough, you will be given Cyltezo to reduce the signs and
Slovenian: Če ta zdravila ne bodo delovala dovolj dobro, boste za zmanjšanje znakov in simptomov bolezni dobili zdravilo Cyltezo.
English: 40 mg Adalimumab every week
Slovenian: 40 mg adalimumaba vsak teden n = 172
English: 5) Clean injection site
Slovenian: 11) Zavrzite napolnjeno injekcijsko brizgo
English: Worsening or new onset of psoriasis (including palmoplantar pustular psoriasis) urticaria, bruising (including purpura), dermatitis (including eczema), onychoclasis, hyperhidrosis, alopecia pruritus
Slovenian: pogosti poslabšanje ali pojav psoriaze (vključno s palmplantarno pustularno psoriazo) urtikarija, modrice (vključno s purpuro), dermatitis (vključno z ekcemom), oniholiza, čezmerno znojenje, alopecija srbenje nočno potenje, brazgotinjenje multiformni eritem Stevens-Johnsonov sindrom angioedem kožni vaskulitis lihenoidna reakcija poslabšanje simptomov dermatomiozitisa mišično-skeletne bolečine mišični spazmi (vključno s povišano kreatin fosfokinazo v krvi)
English: Traceability
Slovenian: A. OZNAČEVANJE
English: Rare (may affect up to 1 in 1,000 people): • leukaemia (cancer affecting the blood and bone marrow);
Slovenian: • levkemija (rak, ki prizadene kri in kostni mozeg);
English: • facial oedema;
Slovenian: • kratka sapa;
English: In case there is a need for a more rapid response to therapy with the awareness that the risk for adverse events may be higher with use of the higher induction dose, the following dose may be used:
Slovenian: ≥ 40 kg • 80 mg v 0. tednu in 40 mg v 2. tednu V primeru, ko je potreben hitrejši odgovor na zdravljenje, z zavedanjem, da je tveganje za pojav neželenih učinkov povečano ob uporabi večjega začetnega odmerka, se lahko uporabi odmerek:
English: ACR Responses in Placebo-Controlled Trials (Percent of Patients) RA Study II a**
Slovenian: Preglednica 7: Odziv po ACR v študijah, kontroliranih s placebom (odstotek bolnikov) Odziv
English: Diplopia
Slovenian: adalimumab
English: Adalimumab 40 mg eow N = 80
Slovenian: adalimumab 80/40 mg n = 75
English: RA study I at 24 weeks, RA study II at 26 weeks, and RA study III at 24 and 52 weeks 40 mg adalimumab administered every other week
Slovenian: Študija revmatoidnega artritisa I po 24 tednih, študija revmatoidnega artritisa II po 26 tednih in študija revmatoidnega p < 0,01, adalimumab v prim.
English: The recommended Cyltezo dose is 80 mg at week 0 followed by 40 mg every other week starting at week 1
Slovenian: Priporočeni odmerek zdravila Cyltezo je 80 mg v 0. tednu, ki mu sledi 40 mg vsak drugi teden z začetkom v 1. tednu, v obliki subkutane injekcije.
English: Clinical response is decrease from baseline in Mayo score ≥ 3 points and ≥ 30 % plus a decrease in the rectal bleeding subscore [RBS] ≥ 1 or an absolute RBS of 0 or 1; * p < 0.05 for adalimumab vs. placebo pairwise comparison of proportions ** p < 0.001 for adalimumab vs. placebo pairwise comparison of proportions
Slovenian: Klinični odgovor pomeni znižanje ocene Mayo od začetka za ≥ 3 in ≥ 30 % ter znižanje podocene rektalne krvavitve [RBS]
English: • 4 pre-filled syringes (0.8 mL sterile solution), each in a blister, with 4 alcohol pads.
Slovenian: • 4 napolnjene injekcijske brizge (0,8 ml sterilne raztopine), vsaka v svojem pretisnem omotu, s
English: • inflammations.
Slovenian: • hepatitis;
English: Hospitalisation rates
Slovenian: Celjenje sluznice
English: Total Sharp
Slovenian: ACR 20
English: In case there is a need for a more rapid response to therapy, the regimen 160 mg at week 0 (given as four 40 mg injections in one day or as two 40 mg injections per day for two consecutive days), 80 mg at week 2 (given as two 40 mg injections in one day), can be used with the awareness that the risk for adverse events is higher during induction.
Slovenian: Če je potreben hitrejši odziv na zdravljenje, lahko uporabite shemo 160 mg 0. teden (aplicirano kot štiri 40 mg injekcije v enem dnevu ali dve 40 mg injekciji na dan dva dni zapored) in 80 mg 2. teden (aplicirano kot dve 40 mg injekcijia v enem dnevu).
English: • inflammation of the skin (such as eczema); • breaking of finger nails and toe nails;
Slovenian: • vnetje kože (kot je ekcem);
English: • 6 pre-filled syringes (0.8 mL sterile solution), each in a blister, with 6 alcohol pads.
Slovenian: • 6 napolnjenih injekcijskih brizg (0,8 ml sterilne raztopine), vsaka v svojem pretisnem omotu, s
English: Keep the syringes in the outer carton in order to protect from light.
Slovenian: Injekcijske brizge shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: Keep the pre-filled syringe in the outer carton in order to protect from light.
Slovenian: Napolnjene injekcijske peresnike shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: Liver failure
Slovenian: Bat igle
English: Table 10:
Slovenian: Preglednica 11:
English: - Keep this leaflet.
Slovenian: Pokrovčka ne sučite.
English: Package leaflet: Information for the patient Cyltezo 40 mg solution for injection in pre-filled syringe Adalimumab
Slovenian: Navodilo za uporabo Cyltezo 40 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku adalimumab
English: There is no relevant use of adalimumab in patients aged less than 2 years for this indication.
Slovenian: Pri bolnikih, starih manj kot 2 leti, adalimumab za to indikacijo ni namenjen.
English: What Cyltezo is and what it is used for 2.
Slovenian: Kaj je zdravilo Cyltezo in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Cyltezo
English: Adalimumab 0.8 mg/kg eow N = 38
Slovenian: adalimumab 0,8 mg/kg vsak drugi teden n = 38
English: Headache
Slovenian: Konica
English: Patients treated with adalimumab usually experienced improvement in haematological signs of chronic inflammation.
Slovenian: Z adalimumabom zdravljenim bolnikom so se ponavadi izboljšali
English: Mean steady-state trough levels of approximately 7 μg/mL were observed in Crohn's disease patients who received a maintenance dose of 40 mg adalimumab every other week.
Slovenian: Pri bolnikih s Crohnovo boleznijo, ki so dobivali vzdrževalni odmerek 40 mg adalimumaba vsak drugi teden, so ugotovili najmanjšo koncentracijo v stanju dinamičnega ravnovesja približno 7 µg/ml.
English: 2) Inspect pen
Slovenian: 6) Odstranite pokrovček
English: Continued therapy should be carefully reconsidered in a patient not responding within this time period.
Slovenian: Pri bolniku, ki se v tem času ne odzove na zdravljenje je treba ponovno razmisliti o nadaljevanju zdravljenja.
English: Age over 65 years
Slovenian: 13 do 17 let
English: • 2 pre-filled syringes (0.8 mL sterile solution), each in a blister, with 2 alcohol pads.
Slovenian: • 2 napolnjeni injekcijski brizgi (0,8 ml sterilne raztopine), vsaka v svojem pretisnem omotu, z
English: • erythema multiforme (inflammatory skin rash);
Slovenian: • edem obraza povezan z alergijskimi reakcijami; • multiformni eritem (vnetje kožnega izpuščaja);
English: Aortic aneurysm, vascular arterial occlusion, thrombophlebitis
Slovenian: Psoriatični artritis in aksialni spondiloartritis, vključno z ankiloznim spondilitisom
English: Muscle spasms (including blood creatine phosphokinase increased)
Slovenian: Bolezni kože in podkožja zelo pogosti izpuščaj (vključno z eksfoliativnim izpuščajem)
English: p-value is from the pairwise comparison of adalimumab monotherapy and methotrexate monotherapy using the Mann-Whitney U test
Slovenian: Vrednost p se nanaša na parno primerjavo monoterapije z adalimumabom in monoterapije z metotreksatom z Mann
English: Endpoint
Slovenian: ASDAS
English: Adults with non-infectious uveitis
Slovenian: Neinfekcijski uveitis pri odraslih in otrocih
English: - if you have blood in your urine that your doctor has not checked.
Slovenian: če imate kri v urinu, ki ga zdravnik ni preiskal.
English: - if you have or have ever had bladder cancer.
Slovenian: če imate ali ste kdaj imeli raka sečnega mehurja.
English: Ísland Vistor hf.
Slovenian: Vistor hf.
English: Your doctor will check whether Glustin is working 3 to 6 months after you start taking it.
Slovenian: Zdravnik bo preveril ali zdravilo Glustin deluje, 3 do 6 mesecev po tem, ko začnete jemati zdravilo.
English: Date of first authorisation: 11/10/2000 Date of latest renewal: 31/08/2010
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM Datum prve odobritve: 11. oktober 2000 Datum zadnjega podaljšanja: 31. avgust 2010
English: not known not known not known not known not known
Slovenian: neznana neznana neznana neznana
English: Approximately half of the study population had at least two of the cardiovascular history entry criteria.
Slovenian: Približno polovica populacije, vključene v študijo, je ustrezala vsaj dvema vstopnima kriterijema kardiovaskularne anamneze.
English: The study population had an average age of 62 years; the average duration of diabetes was 9.5 years.
Slovenian: Starost populacije, vključene v študijo, je bila v povprečju 62 let; povprečno trajanje sladkorne bolezni je bilo 9,5 let.
English: You can usually continue to take other medicines whilst you are being treated with Glustin.
Slovenian: Običajno lahko še naprej jemljete druga zdravila, medtem ko se zdravite z zdravilom Glustin.
English: - if you have a problem with your liver or heart.
Slovenian: če imate težave z jetri ali s srcem.
English: Tell your doctor if - you are, you think you might be or are planning to become pregnant.
Slovenian: Povejte zdravniku če ste noseči, menite, da bi lahko bili noseči ali načrtujete zanositev.
English: Your doctor will tell you the dose to take.
Slovenian: Zdravnik vam bo predpisal odmerek, ki ga morate jemati
English: Use in children and adolescents under 18 years is not recommended.
Slovenian: Otroci in mladostniki Uporaba tega zdravila pri otrocih in mladostnikih, mlajših od 18 let, ni priporočljiva.
English: The safety and efficacy of Glustin in children and adolescents under 18 years of age have not been established.
Slovenian: Varnost in učinkovitost zdravila Glustin pri otrocih in mladostnikih, mlajših od 18 let, nista bili dokazani.
English: Approximately one third of patients were receiving insulin in combination with metformin and/or a sulphonylurea.
Slovenian: Približno tretjina bolnikov je prejemala insulin v kombinaciji z metforminom in/ali sulfonilsečnino.
English: Glustin helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces.
Slovenian: Zdravilo Glustin pomaga nadzorovati raven sladkorja v krvi, če imate sladkorno bolezen tipa 2, in sicer tako, da telesu pomaga bolje izkoristiti insulin, ki ga izdela.
English: What Glustin is and what it is used for
Slovenian: Kaj je zdravilo Glustin in za kaj ga uporabljamo
English: Almost half of the patients had a previous myocardial infarction and approximately 20% had had a stroke.
Slovenian: Skoraj polovica bolnikov je predhodno doživela miokardni infarkt in približno 20% jih je doživelo kap.
English: Glustin has no or negligible influence on the ability to drive and use machines.
Slovenian: Zdravilo Glustin nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
English: Take Glustin daily as prescribed.
Slovenian: Zdravilo Glustin jemljite vsak dan, kakor vam je predpisano.
English: If you take Glustin with other medicines for diabetes, it is more likely that your blood sugar could fall below the normal level (hypoglycaemia).
Slovenian: Če zdravilo Glustin jemljete z drugimi zdravili za zdravljenje sladkorne bolezni, je bolj verjetno, da vrednost krvnega sladkorja pade pod normalno raven (hipoglikemija).
English: The observed excess risk of fractures for women in this dataset on pioglitazone is therefore 0.8 fractures per 100 patient years of use.
Slovenian: Opazovano povečano tveganje za zlom pri ženskah v tej skupini podatkov na pioglitazonu je torej 0,8 zlomov na 100 bolniških let uporabe.
English: Talk to your doctor or pharmacist before taking Glustin (also see section 4) - if you retain water (fluid retention) or have heart failure problems in particular if you are over 75 years old.
Slovenian: Pred začetkom jemanja zdravila Glustin se posvetujte z zdravnikom ali s farmacevtom (glejte tudi poglavje 4): - če zadržujete vodo (zastajanje tekočine v telesu) ali imate težave s srčnim popuščanjem, zlasti če ste starejši od 75 let.
English: not known (frequency cannot be estimated from the available data) - increase in liver enzymes - allergic reactions
Slovenian: neznana pogostnost (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti) povišanje vrednosti jetrnih encimov alergijske reakcije
English: ANNEX IV SCIENTIFIC CONCLUSIONS AND GROUNDS FOR THE VARIATION TO THE TERMS OF THE MARKETING AUTHORISATION(S)
Slovenian: PRILOGA IV ZNANSTVENI ZAKLJUČKI IN PODLAGA ZA SPREMEMBO POGOJEV DOVOLJENJ (DOVOLJENJ) ZA PROMET Z ZDRAVILOM
English: Epidemiological studies have also suggested a small increased risk of bladder cancer in diabetic patients treated with pioglitazone, although not all studies identified a statistically significant increased risk.
Slovenian: Tudi epidemiološke študije kažejo tudi malo večje tveganje za rak mehurja pri bolnikih s sladkorno boleznijo zdravljenih s pioglitazonom, čeprav pri vseh študijah povečanje tveganja ni bilo statistično signifikantno.
English: Almost all subjects (95%) were receiving cardiovascular medicinal products (beta blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II antagonists, calcium channel blockers, nitrates, diuretics, acetylsalicylic acid, statins, fibrates).
Slovenian: Skoraj vsi preiskovanci (95%) so prejemali kardiovaskularna zdravila (zaviralce adrenergičnih receptorjev beta, zaviralce angiotenzinske konvertaze (zaviralce ACE), antagoniste angiotenzina II, zaviralce kalcijevih kanalčkov, nitrate, diuretike, acetilsalicilno kislino, statine, fibrate).
English: Other medicines and Glustin
Slovenian: Druga zdravila in zdravilo Glustin
English: When Glustin is taken in combination with other medicines used to treat diabetes (such as insulin, chlorpropamide, glibenclamide, gliclazide, tolbutamide) your doctor will tell you whether you need to take a smaller dose of your medicines.
Slovenian: Če boste zdravilo Glustin jemali skupaj z drugimi zdravili za zdravljenje sladkorne bolezni (kot so insulin, klorpropamid, glibenklamid, gliklazid, tolbutamid), vam bo zdravnik povedal, če morate jemati nižje odmerke teh zdravil.
English: Before you start taking Glustin you will have a blood sample taken to check your liver function.
Slovenian: Pred začetkom jemanja zdravila Glustin vam bodo odvzeli vzorec krvi, da se preveri delovanje jeter.
English: 5 Oedema was reported in 6-9% of patients treated with pioglitazone over one year in controlled clinical trials.
Slovenian: 5 O edemih so poročali pri 6-9% bolnikov, zdravljenih s pioglitazonom leto dni v kontroliranih kliničnih preskušanjih.
English: Pharmacotherapeutic group: Drugs used in diabetes, blood glucose lowering drugs; excl. insulins; ATC code: A10BG03.
Slovenian: Farmakoterapevtska skupina: Zdravila za zdravljenje diabetesa, antidiabetiki; oznaka ATC: A10BG03